Perinatal Substance Use Disorder (SUD): Practice, Policy, and Equity Considerations for Providing Care in the Fourth Trimester and Beyond
There are devastating trends in maternal morbidity and mortality for individuals with SUD during the postpartum period. Most substance use related perinatal deaths occur after delivery, rather than during pregnancy. The postpartum period, or ‘Fourth Trimester’, includes the 3 to 12 months after the end of pregnancy, typically after birth of an infant. This webinar will highlight promising and evidence-based strategies to decrease stigma and improve screening and linkage to life-saving treatment and recovery supports for this vulnerable patient population.
This webinar will answer the following questions:
• What are the SUD-related risk factors contributing to the rise of maternal morbidity and mortality in the fourth trimester?
• What barriers to treatment and recovery do postpartum individuals with SUD encounter?
• What strategies can advance evidence-based care to better support postpartum individuals with SUD?
• What federal and state policy levers and resources are available to improve maternal health outcomes and address health care inequities experienced by pregnant and parenting individuals with SUD?
Presenter: Kari Earle, M.Ed
Ms. Earle has provided expert technical and capacity building support to multi-disciplinary teams in states, tribe and local governments, and safety net organizations across the United States for the past 20 years to help them to improve maternal, child and family health outcomes for vulnerable populations that are medically underserved, socially marginalized and experience systemic barriers to accessing care and support services. Ms. Earle is a subject matter expert on family-centered treatment, substance use in pregnancy, and children impacted by intrauterine substance exposure. This includes in-depth knowledge about the nation’s opioid crisis and its intergenerational impact on maternal mortality and morbidity.